Fact-checked by Grok 2 weeks ago

Essilor


Essilor is a French multinational corporation specializing in the research, development, manufacture, and distribution of ophthalmic lenses and related optical products.
Founded on October 6, 1971, through the merger of Essel (originating in 1849) and Silor (established in 1931), the company emerged as a dominant force in the French optical sector by combining expertise in lens grinding and progressive lens technology.
Headquartered in Charenton-le-Pont, Essilor pioneered key innovations including the Varilux progressive addition lens in 1959—prior to the merger via Silor—and anti-reflective coatings like Crizal, establishing leadership in vision correction technologies.
In 2018, Essilor combined with Luxottica Group in a $49 billion all-stock transaction to form EssilorLuxottica, creating the world's largest eyewear entity with integrated control over lens production and frame distribution, though the merger faced scrutiny over governance and market concentration.

History

Origins in Essel and Silor (1849–1972)

The origins of Essilor trace back to two distinct French entities: Essel, established through a workers' cooperative in 1849, and Silor, founded in 1931. The Association Fraternelle des Ouvriers Lunetiers was created in Paris by 13 eyewear craftsmen from the Jura region to support mutual aid and collective production amid economic uncertainties of the era. This cooperative evolved into the Société des Lunetiers, known commercially as Essel, specializing in lens grinding, eyeglass assembly, and distribution, embodying a conservative, worker-owned model rooted in artisanal traditions. By the early 20th century, Essel had become a dominant force in France's fragmented optical sector, where small workshops predominated, limiting technological advancement due to scale constraints and manual processes. Silor emerged from the Lissac family's entrepreneurial efforts, with Georges Lissac opening his first optical shop in Paris in 1931 and founding Lissac Frères as a retailer of frames and lenses. The company transitioned into manufacturing, forming the industrial arms SIL (Société Industrielle Lissac) and LOR, which merged into Silor in 1969 following Lissac's death. Silor's key innovation came in 1959 with the launch of , the world's first mass-produced progressive addition lens, developed by engineer Bernard Maitenaz to provide seamless vision correction for without the visible line of . This breakthrough overcame prior optical limitations in achieving gradual power transitions through precise surface geometry, though initial production faced challenges from the complexity of grinding aspheric curves on glass blanks. Prior to their 1972 merger, Essel and Silor operated in a competitive landscape marked by industry fragmentation, with over 1,000 small grinders in hindering efficiency and innovation. Essel's structure emphasized steady craftsmanship but resisted rapid modernization, while Silor's family-driven approach fostered aggressive R&D, yet lacked Essel's extensive grinding network. These complementary yet contrasting models—traditional volume versus technological pioneering—highlighted the need for to address escalating demands for advanced ophthalmic solutions amid post-war optical market growth.

Formation and Early Expansion (1972–1989)

Essilor was formed on January 1, 1972, through the merger of Essel, a specializing in lens grinding and corrective glass , and Silor, an innovator in progressive including the design invented in 1959. The merger combined Essel's manufacturing scale with Silor's technological advancements in plastic like Orma (introduced 1956), enabling in production and distribution while averting direct rivalry in a consolidating market. This integration positioned Essilor as the world's third-largest ophthalmic firm, with initial focus on streamlining operations across to enhance lens grinding efficiency and progressive lens output. To fund expansion, Essilor listed on the in 1975 at an initial share price of FFr 480, which facilitated capital for international growth. Operations consolidated under a dual presidency alternating between Essel and Silor leaders until 1980, alongside the creation of Société Civile Valoptec to promote employee ownership requiring a minimum of five shares per worker. Entry into the U.S., the largest market, began with a manufacturing factory in 1972, supporting local production of corrective lenses and capturing early demand for progressives. By the late , Essilor shifted from reliance—where comprised 45% of revenue—to localized , establishing its first Asian site in the in 1979. The 1980s emphasized through acquisitions of distribution partners and new plants in , , , and , including Essilor of in 1985 and Sudop in in 1986, to control supply chains and reduce dependency on third-party distributors. These moves drove efficiency, with rising from FFr 2.4 billion in 1984 to FFr 4.4 billion in 1988, and securing 50% of the U.S. market by mid-decade, establishing Essilor as the global leader in corrective lenses.

Global Partnerships and Acquisitions (1990–2009)

In 1990, Essilor entered into a with to form , Inc., which developed and commercialized the first plastic photochromic ophthalmic lens, launched in 1991 and marketed under the Transitions brand; this partnership enabled Essilor to diversify into adaptive lens technologies while leveraging PPG's chemical expertise in photochromics. The following year, Essilor established a 50/50 with Nikon Corporation in , named Nikon-Essilor Co., Ltd., to produce and distribute prescription lenses tailored to Asian consumer preferences, marking an early step in regional customization and reducing reliance on European imports. The mid-1990s saw targeted acquisitions to advance material innovations. In 1996, Essilor acquired Gentex Optics, a U.S.-based producer of lenses, integrating high-impact, lightweight materials into its portfolio and enhancing safety-focused products for markets like sports and children's . By 1997, Essilor opened its first production facility in , followed in 2000 by a with local partners to form Shanghai Essilor Optical Company Ltd., which localized lens surfacing and to circumvent tariffs and address surging demand from and aging demographics. Expansion into accelerated in 2005 through a with GKB Opticals, establishing manufacturing capabilities in to produce and single-vision lenses, thereby shortening supply chains and improving cost efficiencies in a high-growth projected to expand with rising rates. These moves into emerging economies emphasized equity partnerships over full ownership to navigate regulatory hurdles and foster , yielding localized production that cut lead times by up to 50% in key regions. The period's strategies correlated with robust financial expansion, as revenue rose from roughly FFr 5.6 billion (approximately €850 million) in 1992 to €3.27 billion by 2009, driven by enhanced global and product diversification that captured shares in photochromic and high-index segments.

Diversification and Pre-Merger Growth (2010–2017)

Essilor's grew steadily during the 2010–2017 period, reaching approximately €6.6 billion in 2012 and climbing to over €7 billion by 2015, with annual figures exceeding €6 billion thereafter, propelled by demand for and single-vision lenses as well as into high-growth regions. This reflected a strategic emphasis on value-added products, where segments accounted for a rising share of sales amid stabilizing mature markets in and . In 2010 alone, hit €3.89 billion, up 13.4% on a constant currency basis—the company's strongest performance in 15 years—driven by robust gains in emerging markets like and , which contributed about 22% of total by the mid-decade. To broaden its ecosystem beyond manufacturing ophthalmic lenses, Essilor pursued diversification into vision care distribution channels, notably through digital and segments. In February 2016, the company acquired Vision Direct Group Ltd., a prominent UK-based online retailer of and eye care products, which generated £33 million in revenue the prior year and operated across with a focus on sales. This move represented an early pilot into for optical products, complementing Essilor's traditional wholesale model and addressing rising consumer preference for convenient access to vision correction amid increasing prevalence in urbanizing populations. Preparatory investments in supported this expansion, with Essilor allocating resources to innovations addressing myopia progression—a condition affecting growing numbers of children and young adults globally, particularly in emerging economies. While specific myopia-control lens launches like Stellest occurred post-2017, the period saw foundational work on aspherical and multifocal designs aimed at slowing axial elongation, building on Essilor's expertise in materials and coatings. R&D efforts scaled to sustain competitive edges in premium technologies, enabling Essilor to capture higher margins from advanced products before the 2018 merger.

Merger with Luxottica and Integration Challenges (2018–2020)

The merger between Essilor and was publicly announced on , 2017, as an all-stock transaction valued at €46 billion ($50 billion), structured with Essilor acquiring Luxottica through a share exchange where Essilor shareholders would own 50% of the combined entity and Luxottica shareholders the remainder, aiming to leverage complementary strengths in lenses and frames for enhanced . Antitrust scrutiny focused on potential monopolistic effects in markets, yet the cleared the deal unconditionally on March 1, 2018, after finding insufficient evidence of competitive harm, while the U.S. simultaneously closed its investigation without remedies, citing the presence of alternative suppliers and innovation incentives post-merger. The transaction closed on October 1, 2018, forming with Essilor as the listing entity, 2017 revenues of €16 billion, and 2018 results showing 3.2% to €16.16 billion alongside adjusted operating margins of 15.9%, though initial synergies emphasized efficiencies over immediate aggressive cost cuts. Integration encountered friction in 2019 when , Luxottica's founder controlling 31% of voting rights via Delfin, publicly accused Essilor executives, including CEO Hubert Sagnières, of breaching the merger's equal governance pact by sidelining Luxottica input on strategy and appointments, potentially jeopardizing €400-600 million in targeted annual synergies. This dispute escalated to arbitration threats and board resignations, eroding €2.5 billion in within days and highlighting coordination costs from mismatched corporate cultures—Essilor's decentralized model versus Luxottica's centralized control—before a settlement reinstated joint leadership under Del Vecchio as executive chairman and refocused on unification, though it delayed full operational alignment. The onset of in 2020 exacerbated challenges, with global lockdowns closing thousands of retail outlets and halting elective vision procedures, resulting in a 14.6% drop to €14.4 billion at constant rates and compressing , which strained capture amid deferred investments and heightened short-term needs despite ongoing acceleration efforts.

Post-Merger and Recent Milestones (2021–Present)

Following the stabilization of integration efforts, achieved consolidated revenues of €25.4 billion in 2023, reflecting a 7.1% increase at constant exchange rates from the prior year and surpassing €20 billion for the first time post-merger, driven by expanded networks and product demand recovery amid global economic rebound. This growth trajectory accelerated into 2025, with third-quarter revenues reaching €6.87 billion, up 11.7% at constant exchange rates—the company's strongest quarterly performance to date—fueled by robust performance across regions and channels, including double-digit gains in wearables. A pivotal tech pivot involved deepening the partnership with , initiated in 2019 and extended long-term in September 2024, to develop AI-enabled smart glasses under brands like and Oakley. The second-generation glasses, launched in October 2023, have sold over 2 million units globally, with revenues tripling year-over-year by mid-2025, positioning eyewear as an emerging platform for integration and contributing significantly to overall sales acceleration. In myopia management, EssilorLuxottica secured U.S. Food and Drug Administration market authorization for Stellest spectacle lenses on September 25, 2025, marking the first such approval for lenses designed to slow pediatric progression based on a two-year demonstrating efficacy in correcting with or without while reducing axial length elongation. This milestone expands access to HALT technology, previously approved in markets like and , underscoring the company's leadership in evidence-based vision correction amid rising global prevalence.

Business Operations

Core Products and Technologies

Essilor's primary ophthalmic products are corrective lenses engineered for and other refractive errors, utilizing advanced polymer materials like high-index plastics (e.g., 1.67 or 1.74 refractive indices) to achieve thinner profiles and lighter weight compared to standard lenses. These lenses incorporate aspheric surfaces to reduce aberrations, enabling broader fields of clear vision by flattening curvature toward the edges, which counters the spherical distortion inherent in traditional multifocal designs. Progressive addition lenses, such as those in the series, achieve seamless transitions across distances via continuous power gradients calculated using wavefront analysis and pupillometry, which model individual eye dynamics to optimize near, intermediate, and far vision zones. This design minimizes swim and effects—optical distortions causing perceived motion—by up to 25% through dual-axis stabilization of the progression corridor. Clinical evaluations report rates exceeding 80% within the first week, with 71% of wearers accessing near vision zones effortlessly and 78% experiencing reduced visual fatigue during dynamic tasks like reading or walking. Photochromic technologies in Transitions lenses embed silver halide nanocrystals that isomerize under ultraviolet exposure, shifting transmittance from 90% indoors to as low as 18% outdoors within 30 seconds, thereby attenuating glare by filtering 85-99% of visible light while blocking 100% of UVA/UVB rays. Polarized variants further enhance glare reduction by up to 33% over non-polarized alternatives through linear dichroic films aligned to block horizontally reflected light from surfaces like roads. Anti-reflective coatings like Crizal apply multilayer dielectric stacks—typically and metal oxides—to induce destructive interference of reflected wavelengths across the (400-700 nm), cutting reflections from 4-8% on uncoated lenses to under 1%, which improves light transmission to over 99% and boosts contrast sensitivity. These coatings also provide bidirectional UV protection via an E-SPF index of 35, absorbing >98% of /UVB from both lens surfaces, and demonstrate empirical durability with 70% higher scratch resistance and 20% better tolerance than prior generations in standardized tests.

Brand Portfolio

Essilor's brand portfolio centers on specialized ophthalmic , with flagship offerings differentiated by their optical technologies for , digital vision demands, and light adaptation. These brands collectively contribute to Essilor's position as a market leader in , holding an estimated 20% global share in ophthalmic alongside its merged entity. Varilux represents Essilor's progressive addition lens line, pioneered in 1959 as the first commercially viable design providing seamless vision correction across distances without visible segments. With over 65 years of refinement, maintains dominance in the multifocal segment, having sold more than 400 million pairs worldwide. Variants incorporate Prevencia, a coating that selectively filters up to 20% of harmful blue-violet light (415-455 nm wavelengths) from digital and solar sources while transmitting beneficial blue-turquoise light essential for circadian regulation. Eyezen targets single-vision users experiencing digital from extended screen exposure, featuring optimized base curves and micro-additions (e.g., +0.40 diopters near power) to alleviate accommodative . Clinical evaluations indicate these lenses significantly reduce computer-induced asthenopia symptoms compared to standard single-vision alternatives. Eyezen also integrates mitigation, filtering at least 20% of high-energy blue-violet rays to counter potential retinal fatigue from devices used over two hours daily by more than 90% of adults. Transitions employs photochromic dyes embedded in the lens material to dynamically adjust tint in response to exposure, darkening outdoors and clearing indoors. The technology achieves activation speeds under 30 seconds under standard lab UV conditions, enabling rapid adaptation to changing light. Recent iterations enhance fade-back rates by up to 39% versus non-photochromic lenses, prioritizing speed in high-contrast environments.

Distribution Networks and Retail Presence

EssilorLuxottica's distribution network leverages a vertically integrated model spanning the , from to final delivery, which facilitates efficient supply to independent opticians and affiliated channels. The company operates 48 facilities and nearly 600 prescription laboratories globally, supported by 118 centers handling lenses, , and related equipment. This infrastructure enables the supply of Essilor's lenses to Luxottica's frame brands and external partners, capturing a leading position in the prescription segment through streamlined and reduced intermediary costs. Manufacturing occurs across multiple countries, including major sites in , , the , , , and recent expansions in , allowing localized production to meet regional demand and mitigate supply chain disruptions. Post-merger synergies with have centralized distribution hubs, such as the Sedico facility in for partner retailers, enhancing throughput for both prescription processing and frame assembly. This integration supports servicing over 80% of major frame brands internally, minimizing external dependencies while maintaining flexibility for wholesale channels. In retail presence, EssilorLuxottica maintains approximately 18,000 stores under 72 banners across 44 countries, attracting around 500 million annual visitors and blending physical outlets with capabilities. Traditional networks remain core, with lenses distributed to independent practices via B2B platforms like my.EssilorLuxottica.com, which streamline ordering and inventory management. Complementing this, direct-to-consumer channels include products available on over 200 online platforms, enabling sales that contrast with reliance on brick-and-mortar by offering and try-ons. This hybrid approach, bolstered by vertical control, ensures broad while adapting to shifting preferences for .

Research and Development Framework

EssilorLuxottica's framework is anchored by substantial annual investments, reaching approximately €600 million in 2023, which exceeds three times the combined R&D expenditures of the broader industry. This level of funding, maintained consistently post-merger, enables a global dedicated to advancing optical technologies through rigorous, data-driven processes rather than speculative approaches. The emphasis on empirical validation is evident in the prioritization of measurable outcomes, such as lens performance metrics derived from controlled testing protocols. The company's R&D operations span over 50 facilities worldwide, with key hubs in (including ), the , and , supporting iterative experimentation on lens geometries, materials, and coatings. These centers facilitate collaborative, region-specific adaptations while adhering to centralized standards for reproducibility and causal analysis of optical variables. In , facilities like those in and coordinate advanced prototyping, complemented by U.S. sites focused on high-volume validation and Asian outposts addressing localized visual correction needs. This infrastructure underpins an extensive foundation, with a portfolio surpassing 11,000 entries as of recent assessments, primarily covering chemical compositions, layering techniques, and design optimizations validated through empirical trials. Such a reflects a systemic focus on proprietary advancements grounded in observable cause-effect relationships in light refraction and material durability, rather than theoretical projections.

Innovations and Scientific Contributions

Key Technological Breakthroughs

Essilor's most enduring technological breakthrough came with the 1959 launch of , the world's first commercially successful progressive addition lens, invented by engineer Bernard Maitenaz to provide continuous vision correction across distances without the image jump associated with . This innovation addressed by gradually varying lens power from distance to near vision, enabling wearers to see clearly at all focal points in a single lens. Subsequent iterations refined the design to minimize peripheral distortions, establishing progressive lenses as a standard for multifocal correction and influencing global adoption rates exceeding millions of units annually by the late . In the realm of lens coatings, Essilor introduced Crizal anti-reflective technology in the early 1990s, applying multilayer thin-film deposition to reduce surface reflections and enhance light transmission while improving scratch resistance and ease of cleaning. Crizal coatings employ hydrophobic and oleophobic properties alongside anti-static elements to repel , , and smudges, resulting in lenses that maintain clarity under various conditions and resist everyday wear. Independent evaluations have confirmed these coatings' efficacy in minimizing for drivers and computer users, with reflection reduction across multiple angles via patented multi-angular deposition processes. Advancements in photochromic lenses materialized through Essilor's collaboration in Transitions Signature GEN 8, released in 2019, which incorporated chemistry refinements for faster darkening in UV light—up to 30% quicker than prior generations—and fade-back to clear states up to three minutes faster indoors. This generation achieved darker tint outdoors while prioritizing rapid recovery for dynamic environments, supported by clinical testing demonstrating reduced adaptation time for wearers transitioning between indoor and outdoor settings. These properties stemmed from optimized molecular activation thresholds, making the lenses suitable for variable light exposure without compromising clear vision in low-UV conditions.

Myopia Management and Lens Advancements

Essilor has pursued research into management for over 45 years, developing spectacle lens technologies aimed at slowing axial elongation and refractive progression in children. This effort addresses the increasing prevalence of , particularly in regions like where rates exceed 80% among young adults due to environmental factors such as intensive near work and limited outdoor time. The Essilor Stellest lens, featuring highly aspherical lenslets (HALT) that induce peripheral defocus, represents a key advancement in this domain. On September 25, 2025, the U.S. authorized its marketing via the pathway as the first spectacle lens clinically demonstrated to slow pediatric progression. Clinical evidence from a two-year involving children aged 8-13 showed that Stellest lenses reduced progression by 71% in spherical equivalent and 53% in axial length compared to single-vision lenses. A separate analysis of the same trial indicated a 67% average slowdown in progression for children wearing the lenses at least 12 hours daily. Longer-term data from a six-year further substantiates efficacy, with Stellest lenses slowing progression by 57% (1.95 diopters) and axial elongation by 52% (0.81 mm) relative to single-vision controls. These findings derive from controlled trials contrasting lens designs against standard corrections, highlighting the role of defocus mechanisms in modulating emmetropization signals without pharmacological intervention. Essilor has prioritized global rollout of such lenses, targeting high-prevalence areas in to mitigate epidemic-level increases projected to affect half of the world's by 2050.

Collaborations in Emerging Technologies

EssilorLuxottica has partnered with since 2021 to develop AI-integrated smart glasses under the brand, incorporating features such as voice-activated assistants, real-time audio transcription, and hands-free camera controls for enhanced user interaction. This collaboration extended to Oakley Meta glasses in 2025, emphasizing seamless integration of eyewear design with computational capabilities. The features have driven significant sales growth, with glasses contributing over four percentage points to EssilorLuxottica's third-quarter revenue increase in 2025, amid overall sales rising 11.7% to €6.9 billion. Sales of these glasses tripled in the first half of 2025 compared to the prior year, with millions of units sold globally since the product's launch, positioning them as the top-selling glasses. In research and development, EssilorLuxottica utilizes (VR) simulations to model vision correction scenarios, enabling precise testing of lens performance in dynamic environments without physical prototypes. These VR applications support AI-driven algorithms that analyze over one million data points to replicate real-world visual conditions, accelerating iteration in wearable development. These initiatives contributed to EssilorLuxottica's recognition as the eighth most innovative company worldwide in Fast Company's 2025 ranking of the World's 50 Most Innovative Companies, with specific acclaim for advancing wearables in . The ranking highlighted the partnership's role in redefining as a platform for , including projected shipments exceeding four million units for glasses in 2025.

Market Dynamics and Competitive Landscape

Industry Dominance and Economic Impact

EssilorLuxottica, formed by the 2018 merger of Essilor and , holds an estimated 20% share of the global market for ophthalmic lenses and as of 2024, positioning it as the industry leader. This market position reflects the combined strengths of Essilor's dominance in corrective lenses—historically around 15% in ophthalmic devices—and Luxottica's control over premium frames and distribution, enabling that smaller fragmented competitors cannot replicate. The resulting scale supports R&D expenditures exceeding €1 billion annually, driving advancements in lens materials and coatings that enhance visual performance and durability. The merger has delivered quantifiable economic efficiencies, with projected annual cost synergies of €400 million to €600 million through , savings, and operational streamlining. These gains, realized progressively post-2018, have lowered expenses and bolstered profitability, allowing reinvestment into that expands the market's overall value—estimated at €120 billion globally. In economic terms, such facilitates unattainable in a pre-merger of numerous small producers, where fixed R&D costs would dilute returns and stifle premium . This dominance contributes positively to global eyewear economics by broadening access to advanced lenses in underserved regions, including developing markets, through EssilorLuxottica's extensive footprint and partnerships that localize production. For instance, the company's expansion in and has increased availability of high-index and progressive lenses, supporting vision correction for over 700 million customers annually and addressing rising prevalence via scalable management solutions like Stellest lenses. These efforts generate economic multipliers, as improved vision correlates with higher in labor-intensive economies.

Antitrust Investigations and Regulatory Challenges

In 2017, the European Commission initiated an in-depth investigation into the proposed merger between Essilor and Luxottica under the EU Merger Regulation, focusing on potential impacts on competition in the ophthalmic lenses and eyewear frames markets. The review concluded on February 28, 2018, with unconditional clearance, determining that the transaction would not significantly impede effective competition in the European Economic Area. Similarly, the U.S. Federal Trade Commission closed its investigation on March 1, 2018, without imposing remedies, as evidence did not indicate anticompetitive effects warranting intervention. Post-merger, regulatory scrutiny intensified in jurisdictions with conditional approvals, particularly , where the (TCA) required behavioral commitments to mitigate dominance risks, including prohibitions on bundling ophthalmic lenses with frames and refusals to supply branded products to retailers. In August 2023, the TCA concluded that violated these commitments through practices such as affiliated sales and supply restrictions, constituting an abuse of dominant position under Article 6 of ; this breach stemmed from inadequate implementation of remedies intended to preserve rival access to essential inputs. The imposed fines totaling approximately €45 million, including €17 million for non-compliance and additional penalties equivalent to TRY 492 million (about €28 million) for dominance exploitation via bundling, with prior sanctions for related violations contributing to cumulative deterrence. In the United States, lawsuits filed in 2023 and 2024 alleged violations of the Sherman Act and Clayton Act, claiming EssilorLuxottica engaged in exclusionary practices like acquiring competitors and imposing long-term exclusive deals to monopolize premium eyewear distribution. These suits sought to restrain anticompetitive conduct but were dismissed by the U.S. District Court for the Southern District of on September 26, 2025, for failure to adequately plead monopolization or conspiracy claims, highlighting insufficient evidence of causal harm beyond regulatory approvals. No post-merger re-examinations by the or EU Commission have resulted in formal enforcement actions, though the Turkish findings underscore how lax remedy enforcement can enable dominance abuses absent robust monitoring.

Criticisms of Pricing and Market Practices

Critics have pointed to substantial markups in the sector, where retail prices for basic frames and lenses often exceed production costs by factors of 5 to 20 times, attributing this to EssilorLuxottica's extensive control over , , and channels. For instance, costs for metal or frames were estimated at $10 to $15 in the and , with lenses at around $5, while average retail prices for simple prescription reached $350 by the . Such disparities have fueled accusations of exploitative enabled by the company's near-duopoly in major markets, where it produces over 80% of branded and influences retail through exclusive licensing and supply agreements. Proponents of EssilorLuxottica's model counter that elevated prices reflect investments in , branding, and , which differentiate products from low-cost generics and recoup costs for innovations like advanced lens coatings and myopia-control technologies. maintains a of over 150 that command premiums due to perceived superior and optical , with gross margins supporting returns on employed exceeding 30%. Moreover, market alternatives such as direct-to-consumer online retailers like offer frames at markups closer to 3-5 times production costs, providing consumers options to bypass traditional channels without sacrificing basic functionality. Empirical analyses of the 2018 Essilor-Luxottica merger present mixed evidence on price impacts, with one study using data from 400 opticians over six years finding that prices for using Essilor lenses decreased relative to competitor lenses post-merger, potentially due to integrated supply efficiencies. However, prices for non-Luxottica frames trended upward over time, suggesting selective competitive dynamics rather than uniform . These findings challenge blanket claims of post-merger gouging, as causal factors like input cost fluctuations and demand for branded features also influence pricing stability, though critics argue the overall limits downward pressure on averages.

Financial Performance

Essilor's revenue demonstrated consistent growth prior to its merger with in October 2018. In 2017, the company achieved consolidated revenue of €7.49 billion, reflecting a 5.3% year-over-year increase driven by expansion in the U.S. market and robust sales in lenses and optical instruments. This built on a trajectory of compound annual growth rates exceeding 10% through much of the and early , fueled by global demand for vision correction solutions, strategic acquisitions, and innovation in premium lens technologies. Profitability in Essilor's core ophthalmic lenses segment maintained operating margins averaging 15-20% pre-merger, supported by high in and , as well as pricing discipline on value-added products like and photochromic lenses. Overall net profit faced headwinds in 2017 from one-time merger-related costs, but underlying earnings reflected the stability of recurring revenue from professional opticians and labs. Following the merger's formation of EssilorLuxottica, early financials incorporated targeted synergies of €400-600 million annually, with cost savings estimated at €220-300 million from efficiencies, general , and sourcing. By 2020, partial realization of these synergies—amid revenue pressures from the downturn—bolstered adjusted operating margins around 18%, aiding recovery through optimized operations and digital initiatives. This period established a baseline for combined entity growth, with lenses retaining elevated margins relative to frames and segments.

Post-Merger Metrics and 2025 Results

In the first half of 2025, EssilorLuxottica reported consolidated revenue of €14.024 billion, reflecting a 7.3% increase at constant exchange rates from the prior year. This growth was supported by expansions in professional solutions and equipment, alongside initial accelerations in wearable technologies. Revenue growth accelerated in the third quarter, reaching €6.867 billion, a 11.7% rise at constant exchange rates, marking the company's strongest quarterly performance to date. For the nine months ended September 2025, cumulative stood at €20.891 billion, up 8.8% at constant exchange rates, with over four percentage points of the third-quarter increase attributed to sales of AI-enabled glasses, particularly models. Adjusted operating for the first half totaled €2.532 billion, yielding a margin of 18.1% of , stable relative to the prior period despite inflationary pressures and variables. The company anticipates maintaining adjusted operating margins in the 19-20% range by , bolstered by efficiencies in high-margin segments like advanced lenses and wearables. As of October 2025, EssilorLuxottica's exceeded €144 billion, reflecting investor confidence in its and adaptability to technology-driven demand. This valuation underscores operational resilience amid global economic fluctuations, with shares reaching all-time highs following the third-quarter disclosure.

Corporate Initiatives

Social and Environmental Programs

Essilor's Vision for Life , launched as a initiative, focuses on providing in underserved regions by local youth in basic eye screenings and spectacle dispensing, enabling them to establish small businesses that distribute affordable . By 2019, the associated Essilor Vision Foundation had delivered over 1.5 million pairs of glasses to individuals in need, primarily in low-income areas, addressing uncorrected refractive errors that affect educational and economic outcomes. These efforts have reached millions through free screenings and prescriptions, with cumulative screenings exceeding 193,000 by earlier benchmarks, though independent verification of long-term health remains limited to self-reported metrics. On the environmental front, Essilor, as part of EssilorLuxottica, has pursued sustainability targets including carbon neutrality for Scopes 1 and 2 emissions by 2025, achieved through energy efficiency improvements in manufacturing and validated by the Science-Based Targets initiative (SBTi) in 2024. The 2023 sustainability report outlined progress in reducing the carbon footprint across operations, with ongoing audits confirming alignment to these goals via enhanced manufacturing processes that lowered emissions intensity. Empirical data from SBTi validations indicate measurable reductions, though full achievement depends on sustained implementation amid global supply chain pressures. Analyses of such CSR efforts, including Essilor's, suggest they often function dually as mechanisms for market differentiation and entry into base-of-the-pyramid segments, where social interventions like training networks expand distribution channels and foster beyond pure . This integration, while yielding verifiable reach, raises questions about the primacy of motives, as studies highlight how access programs correlate with increased sales in emerging markets rather than isolated charitable outcomes.

Philanthropic Partnerships and Outcomes

EssilorLuxottica, through its Essilor brand, partnered with the (FIA) in 2017 to promote vision checks as a key element of , renewing the agreement in 2020 and 2021 to expand global campaigns under the "Action for Good Vision on the Road" initiative. This collaboration emphasizes that poor vision contributes to up to 20% of road accidents in some regions, targeting drivers, cyclists, and pedestrians through awareness drives and integration into FIA's safety programs. Outcomes include heightened public awareness via multimedia campaigns and partnerships with entities like the Automobile Club d'Italia (ACI), though empirical data on direct accident reductions remains limited, with impacts primarily measured in participation rates rather than causal reductions in crashes. In parallel, Essilor engaged with the Queen Elizabeth Diamond Jubilee Trust's Vision Catalyst Fund, launched in April 2018, committing resources to deliver eye health solutions across nations in and , focusing on refractive errors including . This $1 billion initiative aims to provide vision care to underserved populations, with Essilor contributing expertise in myopia management lenses like Stellest, which clinical trials show slow progression by up to 67% over two years in children. In , affiliated OneSight Foundation efforts reached one million people in the first half of 2025 through screenings and distribution, partnering with local governments for sustainable systems, though scalability challenges persist amid broader unmet needs estimated at billions globally. These partnerships yield measurable beneficiary gains, such as improved for screened individuals and potential long-term control via distributed lenses, fostering indirect returns like enhanced brand loyalty among emerging markets. However, without broader systemic interventions like policy-driven or widespread training, outcomes remain incremental, addressing fractions of the 2.7 billion people worldwide with uncorrected vision impairment and failing to alter underlying causal factors like urbanization-driven epidemics in . Empirical scrutiny reveals efficacy tied to program scale, with costs absorbed philanthropically but ROI more evident in reputational capital than transformative shifts.

References

  1. [1]
    Essilor International - Companies History
    Feb 1, 2024 · Essilor was created from Essel and Silor, two companies dating back respectively to 1849 and 1931, which dominated the French optical eyewear ...
  2. [2]
    Essilor International | Encyclopedia.com
    Essilor was founded in 1972 through the merger of two major French eyeglass manufacturers, Essel and Silor. The merger seemed an unlikely marriage at the time.
  3. [3]
    Essilor products | Discover our brands
    Discover our brands ; A game-changing innovation in myopia control. Correct myopia. Control myopia progression ; The new generation of single vision lenses.Varilux · Crizal coatings · Eyezen · XperioMissing: key | Show results with:key
  4. [4]
    Our History - EssilorLuxottica
    Founded in 1974 by the merger of two brands that were started respectively by Angelo Salmoiraghi and Angelo Viganò in the mid-nineteenth century, Salmoiraghi & ...
  5. [5]
    Essilor and Delfin successfully complete the ... - EssilorLuxottica
    Oct 1, 2018 · Essilor and Delfin successfully complete the combination of Essilor and Luxottica by creating EssilorLuxottica, a global leader in the eyecare and eyewear ...
  6. [6]
    Luxottica and Essilor in 46 billion euro merger to create eyewear giant
    Jan 17, 2017 · The merged EssilorLuxottica will have 140,000 staff and will be headquartered and listed in Paris. It will also have a complex governance ...
  7. [7]
    History of Essilor International - FundingUniverse
    The merger seemed an unlikely marriage at the time. Essel's roots stretched back to 1849, when it was founded as a workers' cooperative by 13 eyeglass makers, ...
  8. [8]
    NYLOR®, an eyewear heritage brand of the 50s
    In 1849, 13 eyewear craftsmen from the Jura French region joined together to form the “Association Fraternelle des Lunetiers Ouvriers“. This cooperative ...
  9. [9]
    Essilor International - Company-Histories.com
    Essilor was founded in 1972 through the merger of two major French eyeglass manufacturers, Essel and Silor. The merger seemed an unlikely marriage at the time.Missing: origins | Show results with:origins
  10. [10]
    Essel, Silor and Essilor - Market Vision
    Silor was founded in 1931 as Lissac, a retailer of ophthalmic frames and lenses, which later became a lens manufacturer. In 1959 he launched an absolute ...
  11. [11]
    EssilorLuxottica mourns passing of Bernard Maitenaz, inventor of ...
    Feb 22, 2021 · Bernard Maitenaz's pioneering work revolutionized the eyecare industry and transformed people's lives: to date, more than 700 million Varilux ...Missing: Silor | Show results with:Silor
  12. [12]
    In the early 70s Essilor was mainly an exporting group with its ...
    Dec 17, 2021 · In the early 70s, Essilor was mainly an exporting group, with its international business accounting for 45 percent of its revenute.
  13. [13]
    Essilor - Wikipedia
    It is the world's largest manufacturer of ophthalmic lenses. ... Founded in 1972 out of the merger of two French companies operating in the sector, Essel and ...History · Activity and distribution · Research and development · Brands
  14. [14]
    [PDF] History of Transitions Optical FORMATION - ABDO
    1990: PPG Industries, Inc. and Essilor International SA form the joint venture Transitions Optical, Inc., based in Pinellas Park, Florida.
  15. [15]
    EssilorLuxottica Part II - Asymmetric Ventures
    Oct 14, 2024 · In the 1980s, facing increasing competition, Essilor expanded production to Brazil and Thailand, growing its global distribution network.
  16. [16]
    Led by sales growth in emerging markets, Essilor posts 6.3 ... - Healio
    Essilor International reported consolidated revenue of €3.27 billion for 2009, representing a 6.3% increase from €3.07 billion ...
  17. [17]
    EssilorLuxottica (EL.PA) - Revenue - Companies Market Cap
    Current and historical revenue charts for EssilorLuxottica. As of October 2025 EssilorLuxottica's TTM revenue is of $27.58 Billion USD.
  18. [18]
  19. [19]
    Essilor sees growth in emerging markets
    Mar 16, 2011 · Essilor experienced its fastest growth in 15 years in 2010, with revenue up 13.4 per cent excluding the currency effect to €3.89bn, ...Missing: 2010-2017 | Show results with:2010-2017
  20. [20]
    [PDF] Essilor
    Jan 18, 2017 · The merger of the two champions (namely lenses for Essilor, frames and sunglasses for. Luxottica) is perfectly complementary in terms of R&D, ...
  21. [21]
    Essilor Acquires Vision Direct Group, a U.K.-based Online Contact ...
    Feb 24, 2016 · Essilor International has acquired Vision Direct Group Ltd., one of Europe's leading online contact lens retailers, with revenue of around £33 million in 2015.
  22. [22]
    News Release: Essilor acquires Vision Direct in the UK
    Feb 23, 2016 · Essilor acquires Vision Direct in the UK. Charenton-le-Pont, France (February 23, 2016 - 5:40 p.m.) - In Europe, Essilor International has ...
  23. [23]
    Essilor International Cites Acquisitions and Emerging Markets in Q3 ...
    Oct 22, 2010 · On a like-for-like basis, revenue rose by 2.8 percent, led by strong growth in sales in emerging markets and the sharp recovery in its equipment ...<|control11|><|separator|>
  24. [24]
    One-year myopia control efficacy of spectacle lenses with aspherical ...
    Apr 2, 2021 · In summary, spectacle lenses with aspherical lenslets significantly reduced myopia progression and axial elongation in children. Among the ...<|separator|>
  25. [25]
    EssilorLuxottica Research and Development Expenses 2011-2025
    EssilorLuxottica annual research and development expenses for 2023 were $0.642B, a 1.53% increase from 2022. EssilorLuxottica annual research and development ...Missing: 2010-2017 | Show results with:2010-2017
  26. [26]
    Essilor and Delfin to create a global integrated player in the eyewear ...
    January 16, 2017 – 6.45 a.m CET – Essilor and Delfin today announce the signing of an agreement designed to create an integrated player dedicated to visual ...
  27. [27]
    [PDF] Summary of Commission Decision of 1 March 2018 declaring a ...
    Sep 20, 2018 · On 1 March 2018 the Commission adopted a Decision in a merger case under Council Regulation (EC) No 139/2004.
  28. [28]
    Statement of Federal Trade Commission Concerning the Proposed ...
    Mar 1, 2018 · The Federal Trade Commission issued a statement on its vote to close the investigation of the proposed merger of European eyewear makers Essilor and Luxottica ...Missing: approval | Show results with:approval
  29. [29]
    EssilorLuxottica: 2018 pro forma results - Solid growth,
    Mar 8, 2019 · Pro forma 1 revenue: +3.2% at constant exchange rates · Pro forma 1 adjusted 2 operating profit: 15.9% of revenue · Pro forma 1 adjusted 2 net ...
  30. [30]
    Feud at Ray-Ban Parent Wipes Out Shareholder Gains
    Mar 21, 2019 · Leonardo Del Vecchio, the company's largest shareholder, said Wednesday that Essilor executives are violating the terms of the agreement and the ...
  31. [31]
    EssilorLuxottica tensions exposed as executives fall out | Reuters
    Del Vecchio, who is the group's largest shareholder, accused Sagnieres of attempting a power grab and said the 400-600 million euros of cost-savings that the ...
  32. [32]
  33. [33]
    EssilorLuxottica and Delfin sign settlement agreement to solve ...
    May 13, 2019 · Leonardo Del Vecchio and Hubert Sagnières empowered Francesco Milleri and Laurent Vacherot to immediately focus on integration process, ...
  34. [34]
    [PDF] Full year 2020 results Resilience, digitalization and synergies lead ...
    Feb 9, 2021 · EssilorLuxottica reported revenue of Euro 14,429 million, down 17.0% at current exchange rates and down 14.6% at constant exchange rates1, ...
  35. [35]
    Q4/FY 2023 Results - EssilorLuxottica
    Feb 14, 2024 · We're proud to share these strong results with our stakeholders, delivering another year above 7% revenue growth 1 , including an acceleration in Q4.
  36. [36]
    Q3/9M 2025 Revenue - EssilorLuxottica
    Oct 16, 2025 · Group's revenue +11.7% in the third quarter at constant exchange rates1, +8.8% in the nine months. Wearables major boost, enlarging the ...Missing: CER | Show results with:CER
  37. [37]
    EssilorLuxottica and Meta Announce Long Term Partnership ...
    Sep 17, 2024 · The two companies have been collaborating successfully since 2019, resulting in two generations of Ray-Ban branded smart glasses that broke the ...
  38. [38]
    Ray-Ban Meta Smart Glasses Sales Triple: EssilorLuxottica
    Jul 29, 2025 · The Ray-Ban Meta smart glasses were an unexpected success, selling two million pairs since debuting in October 2023. Last year, Meta CEO Mark ...
  39. [39]
    Ray-Ban Meta smart glasses revenue tripled over the year - CNBC
    Jul 28, 2025 · EssilorLuxottica said the success of the Ray-Ban Meta glasses contributed to its first-half overall sales of 14.02 billion euro (US$16.25 ...
  40. [40]
    Essilor Stellest is the first and only FDA market authorized spectacle ...
    Sep 25, 2025 · The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2.Missing: investments 2010-2017
  41. [41]
    FDA Authorizes Marketing of First Eyeglass Lenses to Slow ...
    Sep 25, 2025 · The FDA evaluated two-years of data from a clinical study that demonstrated the Essilor Stellest eyeglass lenses slowed myopia progression as ...Missing: investments 2010-2017
  42. [42]
    First Myopia Control Spectacle Lens Approved in the US
    Sep 25, 2025 · The FDA decided to authorize commercialization of the Stellest based on positive results of a two-year randomized clinical trial comparing the ...
  43. [43]
  44. [44]
    [PDF] Scientific Paper
    Jul 21, 2025 · This paper will review the main aspects of the Varilux® Physio® extensee™ lens, including the Pupillizer™ lens technology and Dual Booster™ lens ...
  45. [45]
    [PDF] Varilux Lens Technologies
    Calculates both right and left lenses as a pair, which allows patients to transition from near to far and every distance in between smoothly and effortlessly.Missing: core Crizal
  46. [46]
    [PDF] Varilux Physio Enhanced" Technical Paper and Comparative Studies
    Varilux Physio Enhanced" (Essilor) is a new wavefront-corrected progressive lens that incorporates pupil size modeling data into its design. The study evaluates ...
  47. [47]
    Essilor announces release of new progressive lens to improve ...
    Jul 9, 2025 · The lens can also include Near Vision Behavior measurement, which allows for 71% of participants to easily access the near vision zone and 78% ...Missing: aspheric | Show results with:aspheric
  48. [48]
    [PDF] Varilux® - #1 progressive lens brand
    It is the best overall progressive lens¹², offering instant sharpness at all distances even in motion², adaptation from the very first day¹³ and natural eye ...Missing: aspheric rates
  49. [49]
    Essilor Transitions | Intelligent lenses that adapt to you
    Transitions lenses adapt to light, darkening outdoors and clearing indoors. They offer UV protection, blue-violet light filtering, and come in various colors.Missing: core | Show results with:core
  50. [50]
    Essilor Lenses | Transitions™ XTRactive® Polarized™
    Larger View by reducing glare, Transitions™ XTRactive® Polarized™ lenses help improve visibility by up to 33% more than non-polarised sun lenses.
  51. [51]
    Crizal coatings | Essilor
    All Crizal® coatings have unique technologies and benefits while acting as an invisible shield that protects your eyes and your lenses.Crizal technology · Benefits of Crizal Prevencia · Frequently asked questionsMissing: core | Show results with:core
  52. [52]
    [PDF] The research behind the best anti-reflective coating overall1
    Since 2012, Essilor® has introduced an E-SPF35® index, the best index of UV protection on Crizal® clear lenses. This E-SPF® index6 rates the overall UV ...Missing: empirical | Show results with:empirical
  53. [53]
    Essilor enhances clarity of lenses with new coating - Optical Insider
    Jan 4, 2025 · The coating outperforms previous generations offering up to 70 per cent more scratch-resistance1 and up to 20 per cent improvement in thermal ...
  54. [54]
    EssilorLuxottica: A Titan's Gaze on the Eyewear World - LinkedIn
    Jul 19, 2025 · Dominant Market Position: EssilorLuxottica is the undisputed global leader in lenses and eyewear, with an estimated 20% global market share and ...<|separator|>
  55. [55]
  56. [56]
    The History of Progressive Lenses - ZEISS
    Mar 2, 2020 · The year 2019 marks 60 years of "Varilux" – the first commercially successful progressive lens. Originally an engineer, Bernhard Maitenaz (3) ...
  57. [57]
  58. [58]
    Varilux: The Evolution of Innovation - mivision
    Oct 1, 2008 · Varilux is the world's first progressive lens, meaning 'variable light', and is the number one brand, with over 400 million sold since 1959.Missing: share | Show results with:share
  59. [59]
    Discover Crizal Prevencia - Essilor
    Benefits of Crizal Prevencia ; Blue-violet light filtering · Smartly reflects blue-violet light ; Enhanced vision experience · Reduces distracting reflections.
  60. [60]
    Everything to Know About Blue Light and Crizal Prevencia
    Sep 8, 2014 · Crizal Prevencia is proven to filter out harmful blue-violet light by 20% · Crizal Prevencia has an Eye-Sun Protection Factor (E-SPF®) of 25, ...
  61. [61]
    (PDF) Evaluation of the effects of single vision lenses with additional ...
    Aug 6, 2025 · Conclusions: Digital asthenopia induced by computer was significantly reduced by +0.40 EyeZen lenses wearing.
  62. [62]
    [PDF] EYEZEN™+ LENSES SCIENTIFIC OVERVIEW
    EYEZEN+ lenses are a more complete vision solution, reducing harmful blue light by at least 20% and defending against digital eye strain.Missing: studies | Show results with:studies
  63. [63]
    eyezen - Arnold Eyecare Center
    EyeZen Lenses. • More than 90% of adults report using digital devices more than two hours a day, putting them at risk for digital eye strain. • 72.5% of ...Missing: studies | Show results with:studies
  64. [64]
    how do photochromics work? - Transitions Lenses
    The molecules in photochromic technology work by reacting to UV light. However, temperature can have an effect on the reaction time of the molecules. When the ...
  65. [65]
    FAQs | Transitions Light Intelligent Photochromic Lenses
    Transitions® lenses are equipped with patented, photochromic dyes that enable the lenses to rapidly activate, or darken, when they are exposed to the sun's ...
  66. [66]
    New Transitions Optical lenses provide ultra-responsive speed to light
    Mar 4, 2024 · These transition speeds allows for a 39% faster vision recovery from intensely bright lights in comparison to clear lenses. When fading back to ...
  67. [67]
    [PDF] EssilorLuxottica
    Sep 27, 2024 · demonstrated by its decision to postpone dividend payments during the coronavirus pandemic and to pay a scrip dividend over. 2020-23. In ...Missing: savings | Show results with:savings
  68. [68]
    Our Global Footprint - EssilorLuxottica
    We have a global network of 118 distribution centers for lenses, eyewear, contact lenses, instruments, equipment, AFA (apparel, footwear and accessories), and ...
  69. [69]
    Company Share And Competitive Positioning In The Prescription ...
    Essilor Luxottica: Essilor Luxottica holds a leading share in the global prescription lens market. The company's extensive portfolio and strong market presence ...Missing: worldwide | Show results with:worldwide
  70. [70]
    EssilorLuxottica: Global Expansion To Meet Eyecare Needs
    Aug 12, 2024 · In Thailand, EssilorLuxottica's Rayong facility spans 220,000m² and is one of the group's largest manufacturing sites and includes an integrated ...
  71. [71]
    EssilorLuxottica Expands in Laos with New High-Capacity Lens ...
    Jun 13, 2025 · On 11 June, the company inaugurated its second manufacturing site under Essilor Lao Company Ltd. (ELCL) in Savannakhet. This move aims to expand ...
  72. [72]
    EssilorLuxottica relies on global distribution platform - KNAPP
    The company made the strategic decision to build a new distribution center in Sedico, Italy to centralize the logistics for partner retailers, EssilorLuxottica ...Missing: networks | Show results with:networks
  73. [73]
    Our Strategy - EssilorLuxottica
    Our vertically integrated business model lies at the very heart of our success and covers the industry's entire value chain. Vertical integration in ...
  74. [74]
    Digital Transformation - EssilorLuxottica
    Dec 18, 2023 · To start, EssilorLuxottica released the new version of its global B2B e-commerce platform, my.EssilorLuxottica.com, with a fresh interface and ...
  75. [75]
    EssilorLuxottica - Facebook
    Sep 30, 2022 · Did you know that our products are present on more than 200 online platforms? To offer an increasingly integrated brand experience, ...
  76. [76]
    Luxottica reimagines E-commerce — A shopping experience that ...
    Apr 9, 2018 · Luxottica has continuously invested in e-commerce sites to offer clients an increasingly more extensive catalogue, cutting-edge functions and a top-level ...
  77. [77]
    EssilorLuxottica SA - Transforming Vision - MAEG
    Essilor was formed in 1972 with the merger of Essel and Silor. Essel started in 1849 as an eye-wear maker's cooperative and expanded internationally as early ...
  78. [78]
    EssilorLuxottica Part IV: Investment Thesis - Asymmetric Ventures
    Nov 18, 2024 · The revenues 2019 (2020 was affected by Covid-19) were €6.8bn (~$7.5bn), which implies that Essilor has a market share of close to 30-35% of the ...
  79. [79]
    Crizal technology - Essilor
    All Crizal® coatings feature unique beneficial technologies and act as an invisible shield that protects your eyes and your lenses.Missing: details | Show results with:details
  80. [80]
    Crizal® Sapphire™ HR | Essilor - EssilorPRO
    Crizal Sapphire HR offers high transparency, 360° reflection reduction, scratch/smudge resistance, E-SPF35 UV protection, and is easy to clean.
  81. [81]
    Everything You Need To Know About Transitions® Signature® GEN ...
    Dr. Jennifer Chinn talks Transitions Signature GEN 8 Lenses including everything you need to know about the latest in photochromic technology.
  82. [82]
    Lenses 101 - Varilux Comfort - IcareLabs Blog
    Jun 6, 2018 · Varilux progressive lenses were introduced in 1959. The original Varilux Comfort was released in 1993 by Essilor. It was the first progressive ...Missing: debut | Show results with:debut
  83. [83]
    Myopia Awareness Week 2025 - EssilorLuxottica
    May 19, 2025 · EssilorLuxottica is celebrating 45 years of research and experience in myopia, reaffirming its commitment to advance innovation, education, awareness and ...Missing: history | Show results with:history
  84. [84]
    Prevalence of myopia among urban and suburban school children ...
    This article presents the methodology, baseline demographic characteristics and prevalence estimates of myopia among school children in Tamil Nadu, South India.
  85. [85]
    JAMA Ophthalmology publishes two-year clinical trial results of ...
    Apr 1, 2022 · Hence myopia control efficacy increased in children who wore HAL lenses full-time (≥12 hours/day) every day, to 0.99D (67%) slowdown in myopia ...
  86. [86]
    New Six-Year Data Confirms Long-Term Efficacy of Essilor Stellest ...
    Apr 14, 2025 · The six-year results showed that Essilor Stellest lenses slowed myopia progression by 1.95 D (57%) and slowed axial elongation by 0.81 mm (52%) 1 on average.
  87. [87]
    EssilorLuxottica and Meta build on their successful partnership with ...
    Sep 18, 2025 · "At Meta Connect, we're introducing our most advanced lineup of AI glasses, designed for every lifestyle. This includes Meta Ray-Ban Display, ...
  88. [88]
    Ray-Ban maker shares hits all-time high as investors bet on Meta AI ...
    Oct 17, 2025 · Shares in Ray-Ban maker EssilorLuxottica rose 14% to hit an all-time high on Friday, adding nearly $20 billion in market value as investor ...
  89. [89]
    Ray-Ban Meta Sales Triple as Glasses Become 'Next Computing ...
    Jul 28, 2025 · EssilorLuxottica, which partners with Meta on AI glasses, reported the sales of Ray-Ban Meta glasses were up over 200% in the first half.
  90. [90]
    Press Releases - EssilorLuxottica
    Paris, France (October 16, 2025 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the third quarter of 2025 reached Euro 6,867 million ...EssilorLuxottica signs an... · Q1 2025 Revenue · Acquisition of Optegra
  91. [91]
    Vision Care and AR: Two Sides of the Same Coin? - AR Insider
    Oct 16, 2024 · By transforming the virtual images digitally, the display enables the simulation of any lens corrections, real or artificial. The digital ...
  92. [92]
    EssilorLuxottica's Strategic Acquisition of Automation & Robotics
    Aug 4, 2025 · For example, EssilorLuxottica's Varilux XR lenses use AI trained on over 1 million data points to simulate real-world visual scenarios, creating ...
  93. [93]
    The eyewear giant behind the Ray-Ban Meta glasses has big plans
    Mar 18, 2025 · EssilorLuxottica is No. 8 on the list of the World's 50 Most Innovative Companies of 2025. Explore the full list of companies that are ...
  94. [94]
    EssilorLuxottica Ranked Number Eight on Fast Company's 2025 ...
    Mar 21, 2025 · The newest iteration of Ray-Ban Meta blends the sunglass company's heritage designs with AI-enhanced features like Meta AI with Vision, which ...<|separator|>
  95. [95]
    Meta's latest AI Glasses are revolutionizing the wearable technology ...
    Sep 24, 2025 · Meta's AI glasses shipment in 2025 is expected to reach 4 million units, accounting for approximately 80% of the market share. Weighing ...Missing: volume | Show results with:volume
  96. [96]
    [PDF] EssilorLuxottica
    Aug 5, 2024 · EL has solid innovation and marketing capabilities with annual spending in R&D in the range of €300 million-€350 million per year (about 1.5% of ...
  97. [97]
  98. [98]
    Eyewear Industry Giants Essilor and Luxottica Announce Merger
    Jan 16, 2017 · ... cost synergies ranging from €400 million to €600 million in the medium term and accelerating over the long term, Essilor and Delfin said.Missing: savings | Show results with:savings<|separator|>
  99. [99]
    EssilorLuxottica: From Eyecare To Eyewear To Smart Glasses
    Aug 23, 2024 · In South Korea, same story…even for luxury companies, when they started to expand in Japan or in South Korea in the '80s, they were distributed ...
  100. [100]
    EssilorLuxottica Marks 45 Years of Innovation and Research in ...
    May 20, 2025 · EssilorLuxottica Marks 45 Years of Innovation and Research in Myopia Management · Q1: 45 years is a signficant milestone. · Q2: How is ...
  101. [101]
    Evaluating a company's impact (the case of EssilorLuxottica)
    Oct 18, 2024 · EssilorLuxottica has a +0.94 impact score, serving 700M customers, but has market dominance, high emissions, and water use, with a balance of ...Missing: advanced | Show results with:advanced
  102. [102]
    Mergers: in-depth review of Essilor/Luxottica deal - European Union
    Sep 25, 2017 · The European Commission has opened an in-depth investigation to assess the proposed merger between Essilor and Luxottica under the EU Merger Regulation.
  103. [103]
    Mergers: Commission clears Essilor/Luxottica deal
    Feb 28, 2018 · The Commission concluded that the merger would not adversely affect competition in the European Economic Area or any substantial part of it.
  104. [104]
    Sanctions for non-compliance with commitments related to M&As ...
    Dec 28, 2023 · “EssilorLuxottica undertakes not to engage in the affiliated sale of such products, including not refusing to supply branded sunglasses, branded ...
  105. [105]
    EssilorLuxottica Decision: Unpacking The Effects On The Market ...
    Sep 10, 2024 · On 28 August 2023, the Turkish Competition Authority decided that EssilorLuxottica SA violated competition laws by bundling ophthalmic lens and ophthalmic ...
  106. [106]
    EssilorLuxottica fined for non-compliance in Turkey
    Aug 29, 2023 · EssilorLuxottica must pay a €17 million sanction for violating commitments it offered to gain antitrust approval over its acquisition of Essilor.
  107. [107]
    Breaching Merger Remedies May be an Abuse of Dominance
    Jan 17, 2024 · At the end of the investigation, the TCA imposed a fine amounting to TRY 492 million (approx. EUR 28.3 million) on EssilorLuxottica. The ...
  108. [108]
    [PDF] CLASS ACTION COMPLAINT Demand for Jury Plaintiff Peter Brown ...
    Mar 5, 2024 · § 14, to restrain anticompetitive conduct by EssilorLuxottica, the largest Premium-Branded Eyewear company in the world, and to. PETER BROWN, ...
  109. [109]
    EssilorLuxottica defeats consumer antitrust lawsuits over ... - Reuters
    Sep 26, 2025 · Eyewear giant EssilorLuxottica on Friday convinced a U.S. judge to dismiss consumer lawsuits accusing the Ray-Ban maker of monopolizing ...Missing: Sherman 2024
  110. [110]
    The Chronicles of EssilorLuxottica: Can Non-Compliance with ...
    Oct 10, 2024 · Without strong deterrence mechanisms against non-compliance, there is a risk that these conditions will not be fulfilled, potentially ...Missing: challenges | Show results with:challenges
  111. [111]
    LensCrafters, Ray-Ban, and designer brands all mark up their glasses
    Mar 6, 2019 · During the '80s and '90s, it cost about $10 to $15 to make metal or plastic glasses, and about $5 to make lenses, according to Dahan, the ...
  112. [112]
  113. [113]
    Why Do Your Eyeglasses Cost $1,000? - Freakonomics
    Jul 17, 2024 · ... high-end licensing deals are less profitable for EssilorLuxottica. ROSSI: The human intervention on the high-end frames sometimes is higher.
  114. [114]
    Wondering why your glasses are so pricey? One company controls ...
    Sep 20, 2020 · The answer to these high costs, in part, may be due to the market dominance of a single player. EssilorLuxottica is a single company that ...Missing: criticisms | Show results with:criticisms<|separator|>
  115. [115]
    How Ray-Ban maker EssilorLuxottica has disrupted how we see the ...
    Jun 4, 2025 · The compound benefit of vertical integration for EssilorLuxottica was ultimately that it acted as a shield from potential new entrants in ...
  116. [116]
    EssilorLuxottica: Quality Company, Here For The Long Haul
    Mar 26, 2025 · Low costs and premium prices translate to great return on capital employed (ROCE) at 36%. Well positioned to capture significant growth ...
  117. [117]
    Merger of complements: Empirical evidence from the eyewear industry
    Oct 17, 2024 · The merger was first announced in January 2017 and gained its approval by the European Commission and the Federal Trade Commission in March 2018 ...<|separator|>
  118. [118]
    [PDF] Empirical Analyses of Pricing and Sales Strategies in Optical Retail:
    In Chapter 2, we studied the effects of the merger between Essilor and Luxottica. This merger of complements was theorized to decrease the prices of the merging.
  119. [119]
  120. [120]
    Essilor News Release: Solid 2017 earnings Strong fourth quarter
    Mar 1, 2018 · Essilor reported consolidated revenue of around €7.5 billion in 2017 and employs approximately 67,000 people worldwide. It markets its products ...
  121. [121]
    EssilorLuxottica: Full year 2020 results // Resilience, digitalization ...
    Mar 11, 2021 · Full year 2020 results. Resilience, digitalization and synergies lead to strong recovery and solid foundations for the future.
  122. [122]
    Q2/H1 2025 Results - EssilorLuxottica
    Jul 28, 2025 · Sound revenue growth at 7.3% in Q2 and H1. AI glasses speeding up ... financial statements for the six months ended June 30, 2025. The ...
  123. [123]
    EssilorLuxottica sales boosted by Meta AI glasses | Reuters
    Oct 16, 2025 · Ray-Ban maker EssilorLuxottica reported better than expected third-quarter revenue on Thursday, boosted by "booming" sales of wearable ...
  124. [124]
    [PDF] EssilorLuxottica Q2H1 2025 - PRESS RELEASE
    Jun 30, 2025 · The success of Ray-Ban Meta, the launch of Oakley Meta Performance AI glasses and the positive response to Nuance Audio are major milestones for ...
  125. [125]
    Essilorluxottica (EL) - Morningstar
    Nikon Shares Rise After EssilorLuxottica Raises Stake. Global News Select Oct 5, 2025 ... Market Cap: €144.53B. Volume/Avg: 231,188 / 408,368. Key Statistics.
  126. [126]
    Vision For Life™, Essilor's social impact fund ... - EssilorLuxottica
    Jul 22, 2020 · The program trains young under- and unemployed women and men in rural and semi-urban areas to carry out basic vision screening and supports them ...
  127. [127]
    Empowering Communities through Access to Affordable Vision Care
    This initiative recruits and trains under-employed youth in basic vision screening and spectacle dispensing, then empowers them to start their own business to ...
  128. [128]
    [PDF] Your support of Essilor Vision Foundation has provided the gift of ...
    Essilor Vision Foundation has provided over 1.5 million pairs of glasses, giving eyesight to over 1.5 million people in the last decade.
  129. [129]
    [PDF] Vision Foundation Sets Aggressive Goals
    Since 2008, the Essilor Vision Foundation, the non-profit arm of. Essilor of America, has provided 193,000 vision screenings,.<|separator|>
  130. [130]
    Sustainability & Mission - EssilorLuxottica
    Dec 6, 2024 · In 2024, EssilorLuxottica's new carbon emission reduction targets have been validated by the Science-Based Targets initiative (SBTi). This ...Missing: report audits
  131. [131]
    [PDF] Universal Registration Document 2024
    Apr 30, 2025 · The whole is approved by the AMF in accordance with. Regulation (EU) 2017/1129. EssilorLuxottica òò 2024 Universal Registration Document. 1.
  132. [132]
    [PDF] 2023 Sustainability Report EssilorLuxottica - Responsibility Reports
    Jun 22, 2020 · EssilorLuxottica is setting the stage to become carbon neutral (Scopes. 1 & 2) globally by 2025 by continuing to improve energy efficiency ...
  133. [133]
    Corporate Social Responsibility Boosts Value Creation at the Base ...
    Aug 9, 2025 · The paper highlights three levels of CSR engagement at the firm level, which will translate into different strategies, organisations and types ...
  134. [134]
    Corporate social responsibility : a case study on Essilor - DR-NTU
    In the study of Essilor's CSR projects, the report will purport how the company has developed its CSR through the identification of social issues which can ...
  135. [135]
    EssilorLuxottica and the FIA reinforce their commitment to promote ...
    Jul 5, 2021 · EssilorLuxottica and FIA join forces to promote good vision for safer roads. Learn more about their commitment to road safety and eye ...Missing: screening | Show results with:screening
  136. [136]
    EssilorLuxottica and the FIA reinforce their commitment to
    Jul 15, 2021 · EssilorLuxottica will kick off this partnership with a global “Action for good vision on the road” campaign, calling upon all eye care ...Missing: screening | Show results with:screening
  137. [137]
    ACI and EssilorLuxottica Promote Road Safety and Eye Exams in Italy
    Oct 18, 2021 · Together they will promote to the public the “Check your vision” FIA golden rule through an “out of home” and digital awareness campaign. ACI ...Missing: Essilor screening
  138. [138]
    Essilor - News Release: Strong Second Quarter, Delivering
    In April, Essilor formed a partnership with the Vision Catalyst Fund, a $1 billion fund recently launched by the Queen Elizabeth Diamond Jubilee Trust that ...
  139. [139]
    Commonwealth Commits to Bring Sight to Millions
    Apr 17, 2018 · ... Jubilee Trust said: “We couldn't be more delighted that, on the eve of CHOGM, both Essilor and the UK Government have announced new major ...
  140. [140]
    Myopia control efficacy of spectacle lenses with highly aspherical ...
    Mar 5, 2025 · In this 5-year study, HAL spectacles reduced the rate of myopia progression and axial elongation, preventing the equivalent of 3 years of ...Missing: Jubilee Trust Africa Asia
  141. [141]
    The OneSight EssilorLuxottica Foundation Sets New Pace in Africa ...
    Jul 17, 2025 · Our efforts in Ethiopia, among others, demonstrate how close collaboration with governments can accelerate the integration of vision care into ...
  142. [142]
    New partnership to tackle vision care access across Africa
    Apr 16, 2025 · Recognizing the wide-reaching impact of good vision, this partnership aims to expand equitable access to eye care across Africa through ...
  143. [143]
    Impact Stories | One Sight EssilorLuxottica Foundation
    Read inspiring stories of lives changed through One Sight EssilorLuxottica Foundation's vision care initiatives and programs.
  144. [144]
    The Lancet Global Health Commission on Global Eye Health: vision ...
    This Commission was supported by grants from The Queen Elizabeth Diamond Jubilee Trust ... Global prevalence of myopia and high myopia and temporal trends ...
  145. [145]
    OneSight EssilorLuxottica Foundation
    Dec 4, 2023 · Since 2013, the Group's advocacy and philanthropic actions have collectively provided 700 million people with access to permanent vision care ...